Actor and director Meagan Good was visiting her gynecologist for a routine checkup when they discovered an abnormality in her uterus. After testing determined the tissue could potentially become cancerous, it was removed.
“It was a really scary experience cause the first thing I thought was one minute everything’s fine and the next minute everything could be flipped on its head, [and] what if I wasn’t regularly coming in to meet with my gynecologist and what if I wasn’t proactive instead of reactive; where would I be now?” Good told Healthline.
While she had heard of uterine cancer, she didn’t put much thought into it until then.
“Of course, in every scenario, you never think anything’s going to be your story and by the grace of God it hasn’t become my story…part of that depends on me doing my part to take care of myself, to make sure that I get appointments, to make sure that I ask questions,” she said.
Uterine cancer is the fourth most frequently diagnosed cancer for women in the United States.
In 2021, uterine cancer resulted in an estimated 66,570 new cases and 12,940 deaths—and these rates are on the rise, according to the
Good wants to help raise awareness about the risks of uterine cancer and endometrial cancer, which is found in the lining of the uterus and accounts for 90 percent of uterine cancer diagnoses.
“[Many] women don’t have the statistics and don’t have this education and so I want to be a part of making sure [they] get that,” she said.
Good teamed up with the Spot Her campaign to help raise awareness about endometrial cancer. The initiative aims to empower people across generations and cultures to spot the potential signs early.
Symptoms of endometrial cancer include:
“The signs and symptoms of endometrial cancer may be vague and similar to other conditions,” Dr. Ginger J. Gardner, chair of the Foundation for Women’s Cancer, and vice-chair of the department of surgery at Memorial Sloan Kettering Cancer Center in New York, told Healthline.
While Pap test procedures check for cervical cancer or cell changes that may lead to cervical cancer, they do not reliably screen for endometrial cancer. That’s why Gardner said it’s important to know the symptoms of endometrial cancer.
“Knowing and talking about these gynecologic health symptoms with friends, family, and particularly with your healthcare provider can help overcome the stigma around this topic and allow more people to spot what could be endometrial cancer earlier, when it may be more treatable,” she said.
Dr. Elena Pereira, OB/GYN oncologist at Lenox Hill Hospital in New York, said women should also know that there is a direct correlation between the more common form of endometrial cancer, endometrioid-type, and obesity.
“These cancers are driven by the estrogen hormone, which is present at higher levels secondary to obesity. Obesity also causes an increased inflammatory state, which increases the risk of many other types of cancer,” Pereira told Healthline. “Obesity should be considered one of the most important, preventable causes of endometrial cancer.”
Other factors that may increase a person’s risk of developing endometrial cancer include:
“While there are no guaranteed ways to prevent endometrial cancer, there are things you can do that may help lower your risk of developing this disease such as maintaining a healthy weight, diet, and exercise, working with your doctor to receive proper treatment of pre-cancerous cells of the endometrium if they develop, and genetic testing if appropriate,” said Gardner.
Spreading awareness like this is exactly why Good joined Spot Her. She said it allows her to give back.
“[Here’s] an opportunity to be our sister’s keeper and our own keepers, and to bring awareness and to get the education, to know what questions we should be asking our doctors, to take care of our bodies,” she said.
Helping the Black community identify symptoms and risk factors and encouraging them to seek help is particularly close to Good’s heart.
Only 53 percent of Black women with endometrial cancer receive an early diagnosis.
The reasons may be multifactorial added Pereira. She noted that different types of endometrial cancer and studies have shown that the more aggressive subtypes, with worse prognosis, are more likely to be diagnosed in Black women.
“These more aggressive subtypes tend to present at a later stage secondary to the rapid growth and early metastasis of these tumors. In some patient populations, there may also be delay in diagnosis secondary to limited access to medical care,” she said.
Good added that women of color often don’t feel heard by healthcare providers. She hopes to spread an empowering message that despite all the disparities, Black women can take control of their health.
“I want us to be aware that while these things may not be fair, at the end of the day, we are the keepers of ourselves and the only way to be keepers of ourselves is for us to be educated and to be proactive and to be thoughtful about our bodies and about our loved one’s bodies so that when we do go into these offices, fair or not, we are standing up for ourselves,” she said.
Tests to diagnose endometrial cancer include endometrial biopsy during an office exam or dilation and curettage (D&C). Gardner said a pelvic ultrasound is sometimes helpful to take a look at the uterus. However, a biopsy that occurs either in the office or with a D&C is the most reliable way to test for endometrial cancer, she pointed out.
As far as treatment for endometrial cancer, Pereira said it is most effectively treated when diagnosed early.
“In these early endometrial cancers, surgery can be curative. In cases of metastatic disease treatment often involves a combination of surgery, radiation, and chemotherapy. Patients with certain tumor profiles can also be offered targeted therapies, such as hormonal therapies or immunotherapy,” said Pereira.
While the type of treatment often depends on the stage of the disease, and the specific cell type, however, there are other factors that could play a part in choosing an individual treatment plan, said Gardner. These include:
“Surgery is the most common treatment for endometrial cancer, and yet there are a variety of treatment strategies that sometimes also need to be considered,” said Gardner.
As part of the campaign, Good is participating in the Spot Her virtual walk, which encourages people to take steps toward increasing awareness about endometrial cancer. For every mile logged (up to 20 miles per participant) through the Charity Footprints website, or for each use of #SpotHerforEC on social media, Eisai will donate $1 (up to $20,000) between FORCE and SHARE, which provide support for people living with endometrial cancer.
Good is calling on the public to walk along with her virtually.
The walk runs through June 22, 2022. The event is her favorite part of the campaign because it gives her a chance to help build a community across social media that connects people with a similar cause. She said it’s a perfect way for people to make a difference on their own time.
“[With] this you can do something from right where you are. You go walk, you count up the miles, you post, you hashtag #SpotHerforEC, you do it with your moms, your siblings, or by yourself or with your dog or whatever…[you can] encourage other people to be a part of it and be a part of the movement,” she said.
The Healthline News team is committed to delivering content that adheres to the highest editorial standards for accuracy, sourcing, and objective analysis. Every news article is thoroughly fact-checked by members of our Integrity Network. Furthermore, we have a zero-tolerance policy regarding any level of plagiarism or malicious intent from our writers and contributors.
All Healthline News articles adhere to the following standards:
- All referenced studies and research papers must be from reputable and relevant peer-reviewed journals or academic associations.
- All studies, quotes, and statistics used in a news article must link to or reference the original source. The article must also clearly indicate why any statistics presented are relevant.
- All content related to new treatments, drugs, procedures, and so on must clearly describe availability, pricing, side effects, treatment target (e.g., HER2+), known interactions, and off-label use, if appropriate.
- All news articles must include original commentary from at least two qualified sources with appropriate credentials and links to relevant associations or published works.
- Any potential conflicts of interest related to a study or source must be clearly indicated to the reader.
- All news articles must include appropriate background information and context for the specific condition or topic.